Company / Cash per Share
Ventyx Biosciences, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.40
FY2024
5-year range
$0.12 / $5.52
FY2020-FY2024
Trend
-54.8%
vs FY2023
Sector context
#176 of 203
Health Care
What the data says
Ventyx Biosciences, Inc.'s cash per share of $0.40 is lower than 87% of companies in the Health Care sector (FY2024). Cash per Share has declined for 3 consecutive years, from $5.52 in FY2021 to $0.40 in FY2024.
Based on SEC 10-K filings.
0.40 in FY2024 with a 3-year CAGR of -58.4%.
Declined from $1.24 to $0.40 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -58.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 203This company $0.40 Sector average $76.43
▼
-99.5% below sector average
Key checks
Key Insights
- Ventyx Biosciences, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2024, cash per share decreased 54.8% year-over-year.
- Ranks #176 out of 203 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.40 | -54.8% |
| FY2023 | $0.88 | -28.7% |
| FY2022 | $1.24 | -77.6% |
| FY2021 | $5.52 | +4398.4% |
| FY2020 | $0.12 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026